OmniAb, Inc. (OABI)
4.87
-0.12
(-2.40%)
USD |
NASDAQ |
Oct 02, 16:00
4.86
-0.01
(-0.21%)
Pre-Market: 20:00
OmniAb Gross Profit Margin (Quarterly) : 64.01% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 64.01% |
| March 31, 2026 | 49.89% |
| December 31, 2025 | 7.88% |
| September 30, 2025 | -109.2% |
| June 30, 2025 | -26.02% |
| March 31, 2025 | -14.18% |
| December 31, 2024 | 54.59% |
| September 30, 2024 | -18.10% |
| June 30, 2024 | 19.87% |
| March 31, 2024 | -30.20% |
| Date | Value |
|---|---|
| December 31, 2023 | -2.32% |
| September 30, 2023 | 11.56% |
| June 30, 2023 | 30.03% |
| March 31, 2023 | 74.18% |
| December 31, 2022 | 90.73% |
| September 30, 2022 | 34.85% |
| June 30, 2022 | 37.64% |
| March 31, 2022 | 58.38% |
| December 31, 2021 | 78.87% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 26.20% |
| Champions Oncology, Inc. | 48.48% |
| Medpace Holdings, Inc. | 27.56% |
| Charles River Laboratories International, Inc. | 36.29% |
| Avantor, Inc. | 31.73% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -16.65% |
| Return on Assets | -14.54% |
| Return on Invested Capital | -15.47% |
| Profit Margin (Quarterly) | -43.68% |
| Operating Margin (Quarterly) | -48.36% |
| Return on Net Operating Assets | -18.12% |